Top States
Stigma Grow Top StatesApr 2026
Top states where Stigma Grow is active based on indexed sales coverage.
Is this your Brand? Log in to Hoodie!
Apr 2026
We are a cannabis cultivation and processing company positioned advantageously to address the unmet market demands and stigmas within the legal cannabis industry, with potent products designed to disturb the status quo and dramatically shift the conversation from waiting and want...
YoY sales dropped 17.4% for STIGMA GROW, signaling challenges in the <250K tier. Yet, a recent 9.3% sales increase over the last three months indicates a potential turnaround in their pricing strategy.
Categories
Top States
Top states where Stigma Grow is active based on indexed sales coverage.
Trend View
24-Month Trend

Average Price
$11.68
YoY Sales Trend
17.4%
2Y Sales Trend
39.9%
Oral remains dominant at 59.2% but is down 13.4% YoY. Meanwhile, Edibles are surging at +28.1% YoY, highlighting a significant shift in consumer preferences.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 60.2% | $8.17 | 13.4% |
| Concentrates | 22.4% | $31.2 | 26.8% |
| Pre-Rolls | 11.4% | $30.28 | 15.5% |
| Flower | 5.0% | $30.48 | 6.8% |
Trend View
24-Month Trend

Average Price
$11.68
YoY Sales Trend
17.4%
2Y Sales Trend
39.9%
Category Breakout
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 60.2% | $8.17 | 13.4% |
| Concentrates | 22.4% | $31.2 | 26.8% |
| Pre-Rolls | 11.4% | $30.28 | 15.5% |
| Flower | 5.0% | $30.48 | 6.8% |
State Rank Table
| State | Oral | Concentrates | Pre-Roll | Flower |
|---|---|---|---|---|
| Alberta | 3 | 21 | ⊖ | ⊖ |
| British Columbia | 10 | 20 | ⊖ | ⊖ |
STIGMA GROW excels in Alberta (75%) and British Columbia (25%), showcasing a concentrated geographic footprint across 2 states.
| State | Oral | Concentrates | Pre-Roll | Flower |
|---|---|---|---|---|
| 3 | 21 | ⊖ | ⊖ | |
| 10 | 20 | ⊖ | ⊖ |
Market Position
Competitive summary unavailable.
SKU View
Top products for Apr 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1 | Concentrates | 0.3% |
#2 | Concentrates | 29.4% |
#3 | Pre-Rolls | 2.1% |
#4 | Pre-Rolls | 2.0% |
#5 | Concentrates | 8.9% |
#6 | Concentrates | 2.3% |
#7 | Concentrates | 14.1% |
#8 | Pre-Rolls | 15.9% |
Benchmarking
Peer brands benchmarked against Stigma Grow using competitive landscape rank coverage, proximity, and momentum.